High Dose Carfilzomib for Newly Diagnosed Myeloma

NCT02937571 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Carfilzomib
DRUG: Lenalidomide
DRUG: Dexamethasone

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]
[object Object]